MNVC will feature dozens of orthopedic companies and provide attendees with a glimpse of the unmet needs that startups are trying to address.

This strategic move provides Poly Medicure with an entry point into the large global orthopedics market, particularly in the trauma and extremities segment.

The partnership expands SMAIO’s business in the U.S. and drives adoption of its new open platform for customized implant solutions.

Within 3Q25, these companies debuted products to help fix our fractures and deformities in shoulders, pelvis and toes throughout our ages.

Founded in 2016, Isto Biologics is a regenerative medtech company developing and manufacturing orthobiologic products to help patients heal faster.

TiRobot is an autonomous cobot that is not fixed to the operating table, allowing for continuous adjustments throughout the procedure according to surgical needs.

The partners will leverage KORU Medical’s FreedomEDGE infusion system as part of ForCast’s platform for the treatment of periprosthetic joint infection.

The addition of these technologies will allow Demetra to expand its portfolio of infection management solutions.

The next-generation, radiation-free optical navigation complements the Highridge portfolio of enabling technologies.

VergenixSTR for the treatment of tendinopathy is now available in Poland.